Drawing for EXPRESS SCRIPTS PHARMACY

USPTO serial 90106713

EXPRESS SCRIPTS PHARMACY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CALLERY, TIMOTHY JOHN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EXPRESS SCRIPTS PHARMACY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Troy E. Larson

Troy E. Larson CIGNA INTELLECTUAL PROPERTY, INC.1601 CHESTNUT STREET, TL7TWO LIBERTY PLACEPHILADELPHIA, PA 19192

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer application software for providing information regarding prescription medications; downloadable computer application software for pharmacy patients to receive information and updates regarding pharmacy orders, and renewals and alerts regarding prescription medicationsACTIVE—
035Mail order pharmacy services; providing consumer product and pricing information in the field of pharmaceuticals; Drug utilization review servicesACTIVE—
044Healthcare services, namely, wellness and disease management programs; Consulting services in the field of health in the nature of Medicare prescription drug coverage plan services, namely, complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance, and providing information regarding health and safety issues regarding chronic conditions, disease management and providing information regarding health and safety issues regarding chronic conditions; providing information in the field of healthcare; providing information in the fields of healthcare and information regarding the therapeutic properties of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 23, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 23, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 18, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 16, 2023EX4GSOU EXTENSION 4 GRANTED—
Mar 16, 2023EXT4SOU EXTENSION 4 FILED—
Mar 16, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 16, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 14, 2022EX3GSOU EXTENSION 3 GRANTED—
Sep 14, 2022EXT3SOU EXTENSION 3 FILED—
Sep 14, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 16, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 14, 2022EX2GSOU EXTENSION 2 GRANTED—
Mar 14, 2022EXT2SOU EXTENSION 2 FILED—
Mar 14, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 18, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 16, 2021EX1GSOU EXTENSION 1 GRANTED—
Sep 16, 2021EXT1SOU EXTENSION 1 FILED—
Sep 16, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 16, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 19, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 19, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 30, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 14, 2020ALIEASSIGNED TO LIE—
Dec 14, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 14, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Dec 14, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 14, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 14, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 1, 2020DOCKASSIGNED TO EXAMINER—
Sep 15, 2020MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 12, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 14, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance